BAMLET (bovine α-lactalbumin made lethal to tumour cells) is a molecular complex formed by bovine α-lactalbumin and oleic acid. The broad spectrum of benefits of BAMLET identified by the research group at Lund University and the development of a bovine derived complex to make use of BAMLET more broadly, present a very interesting opportunity also in non-prescription products. Hamlet Pharma is therefore progressing with this opportunity with support of experienced external resources. The discussions with the multinational companies are governed by non-disclosure agreements. 

This disclosure contains information that Hamlet is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-11-2020 12:17 CET.